PURPOSE: Implant-associated osteomyelitis still represents a demanding challenge due to unfavourable biological conditions, bacterial properties and incremental resistance to antibiotic treatment. Therefore different bactericide or bacteriostatic implant coatings have been developed recently to control local intramedullary infections. Controlled local release of gentamicin base from a highly lipophilic gentamicin palmitate compound achieves extended intramedullary retention times and thus may improve its bactericide effect. METHODS: Forty male Sprague-Dawley rats were divided into two groups receiving an intramedullary femoral injection of 10(2) colony-forming units (CFU) of a common methicillin susceptible Staphylococcus aureus strain (MSSA Rosenbach) and either an uncoated femur nail (Group I) or a nail coated with gentamicin palmitate (Group II). Animals were observed for 28 and 42 days. Serum haptoglobin and relative weight gain were assessed as well as rollover cultures of explanted femur nails and histological scores of periprosthetic infection in dissected femurs. RESULTS: Implants coated with gentamicin palmitate significantly reduced periprosthetic bacterial growth as well as signs of systemic inflammation compared with uncoated implants. CONCLUSIONS: Gentamicin palmitate appears to be a viable coating for the prevention of implant-associated infections. These findings will have to be confirmed in larger animal models as well as in clinical trials.
PURPOSE: Implant-associated osteomyelitis still represents a demanding challenge due to unfavourable biological conditions, bacterial properties and incremental resistance to antibiotic treatment. Therefore different bactericide or bacteriostatic implant coatings have been developed recently to control local intramedullary infections. Controlled local release of gentamicin base from a highly lipophilic gentamicin palmitate compound achieves extended intramedullary retention times and thus may improve its bactericide effect. METHODS: Forty male Sprague-Dawley rats were divided into two groups receiving an intramedullary femoral injection of 10(2) colony-forming units (CFU) of a common methicillin susceptible Staphylococcus aureus strain (MSSA Rosenbach) and either an uncoated femur nail (Group I) or a nail coated with gentamicin palmitate (Group II). Animals were observed for 28 and 42 days. Serum haptoglobin and relative weight gain were assessed as well as rollover cultures of explanted femur nails and histological scores of periprosthetic infection in dissected femurs. RESULTS: Implants coated with gentamicin palmitate significantly reduced periprosthetic bacterial growth as well as signs of systemic inflammation compared with uncoated implants. CONCLUSIONS:Gentamicin palmitate appears to be a viable coating for the prevention of implant-associated infections. These findings will have to be confirmed in larger animal models as well as in clinical trials.
Authors: Christine S Lewis; Jordan Katz; Maribel I Baker; Peter R Supronowicz; Elise Gill; Ronald R Cobb Journal: J Biomater Appl Date: 2010-09-06 Impact factor: 2.646
Authors: Lars Helbig; Hans Georg Simank; Helga Lorenz; Cornelia Putz; Christoph Wölfl; Arnold J Suda; Arash Moghaddam; Gerhard Schmidmaier; Thorsten Guehring Journal: Int Orthop Date: 2013-10-30 Impact factor: 3.075
Authors: Khalid Seghrouchni; Christian van Delden; Dennis Dominguez; Mohamed Benkabouche; Louis Bernard; Mathieu Assal; Pierre Hoffmeyer; Ilker Uçkay Journal: Int Orthop Date: 2011-10-05 Impact factor: 3.075
Authors: P S Giffen; J Turton; C M Andrews; P Barrett; C J Clarke; K-W Fung; M R Munday; I F Roman; R Smyth; K Walshe; M J York Journal: Arch Toxicol Date: 2003-03-22 Impact factor: 5.153
Authors: David Alexander Back; Nicole Bormann; Arash Calafi; Julie Zech; Leif Alexander Garbe; Martin Müller; Christian Willy; Gerhard Schmidmaier; Britt Wildemann Journal: Int Orthop Date: 2016-02-23 Impact factor: 3.075
Authors: Malley A Gautreaux; Luke J Tucker; Xavier J Person; Haley K Zetterholm; Lauren B Priddy Journal: J Orthop Res Date: 2022-04-03 Impact factor: 3.102
Authors: Johannes Maximilian Wagner; Hannah Zöllner; Christoph Wallner; Britta Ismer; Jessica Schira; Stephanie Abraham; Kamran Harati; Marcus Lehnhardt; Björn Behr Journal: PLoS One Date: 2016-02-12 Impact factor: 3.240
Authors: Elysia A Masters; Ryan P Trombetta; Karen L de Mesy Bentley; Brendan F Boyce; Ann Lindley Gill; Steven R Gill; Kohei Nishitani; Masahiro Ishikawa; Yugo Morita; Hiromu Ito; Sheila N Bello-Irizarry; Mark Ninomiya; James D Brodell; Charles C Lee; Stephanie P Hao; Irvin Oh; Chao Xie; Hani A Awad; John L Daiss; John R Owen; Stephen L Kates; Edward M Schwarz; Gowrishankar Muthukrishnan Journal: Bone Res Date: 2019-07-15 Impact factor: 13.567